Yang Niuhua Hopes the Second Review of Yu Hua Ying Will Uphold the Death Sentence, Firmly Faces the PronouncementSpecial teams bungles dominate NFL, with Commanders and Cowboys leading the way
A stroke changed a teacher’s life. How a new electrical device is helping her move
Despite the physical and emotional toll of his illness, Vandersa found strength in the support of his loved ones and the resilience of his own spirit. He embraced a newfound appreciation for life, cherishing each moment and expressing gratitude for the second chance he had been given. The experience of facing his mortality head-on had transformed him, imparting a deeper sense of empathy, humility, and gratitude.Xavier Clarke to coach Indigenous All Stars team in Perth exhibition clash next February
As the clock ticks closer to kickoff, anticipation and excitement will reach fever pitch among fans of both teams and football enthusiasts around the world. The clash between Real Madrid and the Serie A leaders promises to be a spectacle of elite football, with high drama, intense action, and moments of brilliance that will keep viewers on the edge of their seats.Technip Energies and LanzaTech Awarded Funding from the U.S. Department of Energy for Commercializing Breakthrough CO2 to Ethylene Technology
Juventus, led by their experienced manager Massimiliano Allegri, have been a dominant force in Italian football for years. With a star-studded lineup including the likes of Cristiano Ronaldo, Paulo Dybala, and Giorgio Chiellini, Juventus possess both the defensive solidity and attacking prowess needed to compete at the highest level. The Turin-based club will be looking to defend their title with all their might, and overcoming the challenge posed by Manchester City will be crucial in their quest for European glory.Mystery drone sightings continue in New Jersey and across the US. Here's what we know
A stroke changed a teacher’s life. How a new electrical device is helping her moveBy Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Related Articles Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.
In the meantime, the political landscape in South Korea remains uncertain, with the arrest of high-ranking officials casting a shadow over the future direction of the country. The consequences of these developments are likely to be felt not only in domestic politics but also in South Korea's relations with its neighbors and partners. How the government and legal system handle these cases will shape the country's reputation and credibility on the world stage.
Enhancing cold chain logistics in PHL
Italian media outlets are abuzz with the latest news surrounding the young talent Sebastiano Esposito, who has been making waves during his loan spell at Empoli. The 19-year-old forward has impressed with his performances for the Serie B club, catching the eye of many with his goal-scoring abilities and overall contribution to the team.In addition to educating minors, the "Prosecutors' Public Classes" series also serves as a platform for dialogue and interaction between prosecutors and young viewers. Through live Q&A sessions and interactive discussions, prosecutors address common legal queries and concerns raised by the audience, fostering a sense of transparency and accessibility in the legal system. By establishing a direct line of communication with minors, prosecutors can build trust and rapport, encouraging open dialogue and mutual understanding.According to Professor Jorma Ryhänen , head of hand surgery at HUS, the operation involved three stages: removal of the donor hand, preparation of the recipient, and attachment of the hand. In the final stage, surgeons connected bones and blood vessels first, followed by tendons, nerves, and other structures — a process requiring the attachment of dozens of individual components. Careful preparation preceded the surgery. The patient underwent extensive evaluations to determine suitability for the procedure. After surgery, the patient spent about a week in intensive care and several weeks in hospital care. Recovery will continue for over a year, with regular follow-ups to monitor the transplant's functionality and sensation. Achieving success in a hand transplant depends on nerve and muscle recovery. In wrist-level transplants, patients typically regain basic finger movement and sensation in the fingertips. Fine motor skills and grip strength, however, remain below the level of a natural hand. Though it is too early to fully evaluate the results of this transplant, Professor Ryhänen noted that initial signs are promising. The loss of hands often results from severe infections or injuries, such as burns or war wounds. While prosthetics have advanced significantly, they lack the sensation and dexterity of a natural hand. Hand transplants offer an alternative for patients who have lost both hands and aim to improve quality of life rather than provide a life-saving measure. Compatibility between the donor and recipient is crucial, considering factors such as tissue type, gender, skin tone, and age. The world’s first successful hand transplant took place in France in 1998. Since then, around 120 hand transplants have been performed globally, with the best outcomes seen in wrist-level procedures where the patient’s own forearm muscles can quickly regain control of the fingers. The success of this procedure follows years of preparation by a multidisciplinary team at HUS, including specialists in hand surgery, plastic surgery, organ transplantation, pathology, anesthesiology, and nursing. The team practiced the surgery on cadavers and studied hand transplantation techniques abroad. Two surgical teams were required for the operation. According to Chief Medical Officer Markku Mäkijärvi , establishing hand transplantation services at HUS demands substantial resources and expertise across multiple medical fields. With the first successful transplant now complete, HUS aims to integrate this procedure into its regular services, building on its well-established organ transplantation and hand surgery units. HT